nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—HTR2A—phrenic nerve—thymus cancer	0.0606	0.337	CbGeAlD
Donepezil—Goitre—Octreotide—thymus cancer	0.0222	0.0271	CcSEcCtD
Donepezil—HTR2A—pulmonary artery—thymus cancer	0.022	0.122	CbGeAlD
Donepezil—HTR2A—vein—thymus cancer	0.02	0.111	CbGeAlD
Donepezil—HRH3—hematopoietic system—thymus cancer	0.0175	0.0974	CbGeAlD
Donepezil—Hernia—Octreotide—thymus cancer	0.0169	0.0206	CcSEcCtD
Donepezil—Abdominal bloating—Octreotide—thymus cancer	0.0167	0.0203	CcSEcCtD
Donepezil—Epigastric pain—Octreotide—thymus cancer	0.0164	0.02	CcSEcCtD
Donepezil—Creatine phosphokinase increased—Octreotide—thymus cancer	0.0151	0.0184	CcSEcCtD
Donepezil—Ear disorder—Octreotide—thymus cancer	0.0147	0.0179	CcSEcCtD
Donepezil—Cholecystitis—Octreotide—thymus cancer	0.0138	0.0168	CcSEcCtD
Donepezil—Fracture—Octreotide—thymus cancer	0.0137	0.0166	CcSEcCtD
Donepezil—Multiple fractures—Octreotide—thymus cancer	0.0137	0.0166	CcSEcCtD
Donepezil—Haemorrhoids—Octreotide—thymus cancer	0.0135	0.0165	CcSEcCtD
Donepezil—Transaminases increased—Octreotide—thymus cancer	0.013	0.0159	CcSEcCtD
Donepezil—Cholelithiasis—Octreotide—thymus cancer	0.0128	0.0156	CcSEcCtD
Donepezil—Paranoia—Octreotide—thymus cancer	0.0116	0.0142	CcSEcCtD
Donepezil—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.0115	0.0141	CcSEcCtD
Donepezil—Neuralgia—Octreotide—thymus cancer	0.0114	0.0139	CcSEcCtD
Donepezil—Metrorrhagia—Octreotide—thymus cancer	0.0111	0.0135	CcSEcCtD
Donepezil—Throat sore—Octreotide—thymus cancer	0.011	0.0134	CcSEcCtD
Donepezil—Oropharyngeal discomfort—Octreotide—thymus cancer	0.0109	0.0133	CcSEcCtD
Donepezil—Herpes zoster—Octreotide—thymus cancer	0.0105	0.0128	CcSEcCtD
Donepezil—Otitis media—Octreotide—thymus cancer	0.0102	0.0124	CcSEcCtD
Donepezil—Numbness—Octreotide—thymus cancer	0.00957	0.0117	CcSEcCtD
Donepezil—Sensory loss—Octreotide—thymus cancer	0.00916	0.0112	CcSEcCtD
Donepezil—Contusion—Octreotide—thymus cancer	0.0091	0.0111	CcSEcCtD
Donepezil—Rectal haemorrhage—Octreotide—thymus cancer	0.00879	0.0107	CcSEcCtD
Donepezil—Oropharyngeal pain—Octreotide—thymus cancer	0.00873	0.0106	CcSEcCtD
Donepezil—Arthropathy—Octreotide—thymus cancer	0.00873	0.0106	CcSEcCtD
Donepezil—Cellulitis—Octreotide—thymus cancer	0.00873	0.0106	CcSEcCtD
Donepezil—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00873	0.0106	CcSEcCtD
Donepezil—Hearing impaired—Octreotide—thymus cancer	0.00834	0.0102	CcSEcCtD
Donepezil—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00794	0.00967	CcSEcCtD
Donepezil—Vaginal inflammation—Octreotide—thymus cancer	0.00794	0.00967	CcSEcCtD
Donepezil—Eructation—Octreotide—thymus cancer	0.0078	0.0095	CcSEcCtD
Donepezil—Cystitis noninfective—Octreotide—thymus cancer	0.00775	0.00945	CcSEcCtD
Donepezil—Wheezing—Octreotide—thymus cancer	0.00771	0.00939	CcSEcCtD
Donepezil—Cystitis—Octreotide—thymus cancer	0.00766	0.00934	CcSEcCtD
Donepezil—Vaginal infection—Octreotide—thymus cancer	0.00749	0.00913	CcSEcCtD
Donepezil—Cramps of lower extremities—Octreotide—thymus cancer	0.00729	0.00889	CcSEcCtD
Donepezil—Bladder pain—Octreotide—thymus cancer	0.00718	0.00875	CcSEcCtD
Donepezil—Diabetes mellitus—Octreotide—thymus cancer	0.00662	0.00807	CcSEcCtD
Donepezil—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00662	0.00807	CcSEcCtD
Donepezil—Gastroenteritis—Octreotide—thymus cancer	0.0065	0.00792	CcSEcCtD
Donepezil—Cardiac failure congestive—Octreotide—thymus cancer	0.00635	0.00774	CcSEcCtD
Donepezil—Injury—Octreotide—thymus cancer	0.00627	0.00764	CcSEcCtD
Donepezil—Hot flush—Octreotide—thymus cancer	0.00616	0.00751	CcSEcCtD
Donepezil—Menopausal symptoms—Octreotide—thymus cancer	0.00611	0.00744	CcSEcCtD
Donepezil—ACHE—thyroid gland—thymus cancer	0.00605	0.0337	CbGeAlD
Donepezil—Arthritis—Octreotide—thymus cancer	0.00593	0.00723	CcSEcCtD
Donepezil—Hypoglycaemia—Octreotide—thymus cancer	0.0059	0.0072	CcSEcCtD
Donepezil—Osteoarthritis—Octreotide—thymus cancer	0.00576	0.00702	CcSEcCtD
Donepezil—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00576	0.00702	CcSEcCtD
Donepezil—Psychotic disorder—Octreotide—thymus cancer	0.00563	0.00686	CcSEcCtD
Donepezil—Irritability—Octreotide—thymus cancer	0.0055	0.0067	CcSEcCtD
Donepezil—Dehydration—Octreotide—thymus cancer	0.00536	0.00653	CcSEcCtD
Donepezil—Dry skin—Octreotide—thymus cancer	0.00528	0.00644	CcSEcCtD
Donepezil—Abdominal pain upper—Octreotide—thymus cancer	0.00526	0.00641	CcSEcCtD
Donepezil—Cramp muscle—Octreotide—thymus cancer	0.00519	0.00632	CcSEcCtD
Donepezil—Nasopharyngitis—Octreotide—thymus cancer	0.00515	0.00628	CcSEcCtD
Donepezil—Gastritis—Octreotide—thymus cancer	0.0051	0.00621	CcSEcCtD
Donepezil—Muscular weakness—Octreotide—thymus cancer	0.00508	0.00619	CcSEcCtD
Donepezil—Abdominal distension—Octreotide—thymus cancer	0.00501	0.00611	CcSEcCtD
Donepezil—Asthma—Octreotide—thymus cancer	0.00498	0.00607	CcSEcCtD
Donepezil—Influenza—Octreotide—thymus cancer	0.00498	0.00607	CcSEcCtD
Donepezil—Pancreatitis—Octreotide—thymus cancer	0.00488	0.00595	CcSEcCtD
Donepezil—Sweating increased—Octreotide—thymus cancer	0.00485	0.00591	CcSEcCtD
Donepezil—SIGMAR1—cardiac atrium—thymus cancer	0.00482	0.0268	CbGeAlD
Donepezil—Bronchitis—Octreotide—thymus cancer	0.00479	0.00584	CcSEcCtD
Donepezil—Abdominal discomfort—Octreotide—thymus cancer	0.00477	0.00582	CcSEcCtD
Donepezil—SIGMAR1—pituitary gland—thymus cancer	0.00471	0.0262	CbGeAlD
Donepezil—Dysuria—Octreotide—thymus cancer	0.00466	0.00568	CcSEcCtD
Donepezil—Pollakiuria—Octreotide—thymus cancer	0.0046	0.00561	CcSEcCtD
Donepezil—HTR2A—neck—thymus cancer	0.00454	0.0253	CbGeAlD
Donepezil—Weight increased—Octreotide—thymus cancer	0.00453	0.00552	CcSEcCtD
Donepezil—Weight decreased—Octreotide—thymus cancer	0.0045	0.00549	CcSEcCtD
Donepezil—Hyperglycaemia—Octreotide—thymus cancer	0.00449	0.00547	CcSEcCtD
Donepezil—Pneumonia—Octreotide—thymus cancer	0.00447	0.00544	CcSEcCtD
Donepezil—Depression—Octreotide—thymus cancer	0.00443	0.0054	CcSEcCtD
Donepezil—Jaundice—Octreotide—thymus cancer	0.00433	0.00527	CcSEcCtD
Donepezil—Urinary tract infection—Octreotide—thymus cancer	0.00432	0.00526	CcSEcCtD
Donepezil—Conjunctivitis—Octreotide—thymus cancer	0.00432	0.00526	CcSEcCtD
Donepezil—Haematuria—Octreotide—thymus cancer	0.00423	0.00516	CcSEcCtD
Donepezil—Epistaxis—Octreotide—thymus cancer	0.00419	0.0051	CcSEcCtD
Donepezil—CYP2C9—hematopoietic system—thymus cancer	0.00411	0.0229	CbGeAlD
Donepezil—SIGMAR1—bone marrow—thymus cancer	0.00407	0.0227	CbGeAlD
Donepezil—SIGMAR1—thyroid gland—thymus cancer	0.00406	0.0226	CbGeAlD
Donepezil—Bradycardia—Octreotide—thymus cancer	0.00406	0.00495	CcSEcCtD
Donepezil—Rhinitis—Octreotide—thymus cancer	0.004	0.00487	CcSEcCtD
Donepezil—Hepatitis—Octreotide—thymus cancer	0.00399	0.00486	CcSEcCtD
Donepezil—Hypoaesthesia—Octreotide—thymus cancer	0.00397	0.00483	CcSEcCtD
Donepezil—Pharyngitis—Octreotide—thymus cancer	0.00396	0.00482	CcSEcCtD
Donepezil—Oedema peripheral—Octreotide—thymus cancer	0.00393	0.00479	CcSEcCtD
Donepezil—Visual impairment—Octreotide—thymus cancer	0.00384	0.00468	CcSEcCtD
Donepezil—ACHE—lymph node—thymus cancer	0.00376	0.0209	CbGeAlD
Donepezil—Tinnitus—Octreotide—thymus cancer	0.00372	0.00453	CcSEcCtD
Donepezil—SIGMAR1—lung—thymus cancer	0.00369	0.0205	CbGeAlD
Donepezil—Arrhythmia—Octreotide—thymus cancer	0.00356	0.00434	CcSEcCtD
Donepezil—Alopecia—Octreotide—thymus cancer	0.00352	0.00429	CcSEcCtD
Donepezil—Mental disorder—Octreotide—thymus cancer	0.00349	0.00426	CcSEcCtD
Donepezil—Erythema—Octreotide—thymus cancer	0.00347	0.00423	CcSEcCtD
Donepezil—Malnutrition—Octreotide—thymus cancer	0.00347	0.00423	CcSEcCtD
Donepezil—Flatulence—Octreotide—thymus cancer	0.00342	0.00417	CcSEcCtD
Donepezil—Tension—Octreotide—thymus cancer	0.0034	0.00415	CcSEcCtD
Donepezil—HTR2A—hematopoietic system—thymus cancer	0.00338	0.0188	CbGeAlD
Donepezil—Nervousness—Octreotide—thymus cancer	0.00337	0.00411	CcSEcCtD
Donepezil—Back pain—Octreotide—thymus cancer	0.00336	0.00409	CcSEcCtD
Donepezil—Muscle spasms—Octreotide—thymus cancer	0.00334	0.00407	CcSEcCtD
Donepezil—Vision blurred—Octreotide—thymus cancer	0.00327	0.00399	CcSEcCtD
Donepezil—Tremor—Octreotide—thymus cancer	0.00325	0.00396	CcSEcCtD
Donepezil—Ill-defined disorder—Octreotide—thymus cancer	0.00322	0.00392	CcSEcCtD
Donepezil—Anaemia—Octreotide—thymus cancer	0.00321	0.00391	CcSEcCtD
Donepezil—Agitation—Octreotide—thymus cancer	0.00319	0.00389	CcSEcCtD
Donepezil—CYP3A4—hematopoietic system—thymus cancer	0.00313	0.0174	CbGeAlD
Donepezil—Malaise—Octreotide—thymus cancer	0.00313	0.00381	CcSEcCtD
Donepezil—Vertigo—Octreotide—thymus cancer	0.00312	0.0038	CcSEcCtD
Donepezil—Syncope—Octreotide—thymus cancer	0.00311	0.00379	CcSEcCtD
Donepezil—HTR2A—epithelium—thymus cancer	0.00309	0.0172	CbGeAlD
Donepezil—CYP2D6—hematopoietic system—thymus cancer	0.00308	0.0172	CbGeAlD
Donepezil—Loss of consciousness—Octreotide—thymus cancer	0.00305	0.00372	CcSEcCtD
Donepezil—Cough—Octreotide—thymus cancer	0.00303	0.00369	CcSEcCtD
Donepezil—Convulsion—Octreotide—thymus cancer	0.00301	0.00366	CcSEcCtD
Donepezil—Hypertension—Octreotide—thymus cancer	0.003	0.00365	CcSEcCtD
Donepezil—Chest pain—Octreotide—thymus cancer	0.00295	0.0036	CcSEcCtD
Donepezil—Myalgia—Octreotide—thymus cancer	0.00295	0.0036	CcSEcCtD
Donepezil—Arthralgia—Octreotide—thymus cancer	0.00295	0.0036	CcSEcCtD
Donepezil—Anxiety—Octreotide—thymus cancer	0.00294	0.00359	CcSEcCtD
Donepezil—Discomfort—Octreotide—thymus cancer	0.00292	0.00356	CcSEcCtD
Donepezil—Dry mouth—Octreotide—thymus cancer	0.00289	0.00352	CcSEcCtD
Donepezil—Oedema—Octreotide—thymus cancer	0.00283	0.00345	CcSEcCtD
Donepezil—Infection—Octreotide—thymus cancer	0.00281	0.00343	CcSEcCtD
Donepezil—Shock—Octreotide—thymus cancer	0.00279	0.0034	CcSEcCtD
Donepezil—Nervous system disorder—Octreotide—thymus cancer	0.00278	0.00338	CcSEcCtD
Donepezil—Thrombocytopenia—Octreotide—thymus cancer	0.00277	0.00338	CcSEcCtD
Donepezil—Hyperhidrosis—Octreotide—thymus cancer	0.00274	0.00334	CcSEcCtD
Donepezil—Anorexia—Octreotide—thymus cancer	0.0027	0.00329	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00258	0.00314	CcSEcCtD
Donepezil—Insomnia—Octreotide—thymus cancer	0.00256	0.00312	CcSEcCtD
Donepezil—Paraesthesia—Octreotide—thymus cancer	0.00254	0.0031	CcSEcCtD
Donepezil—Dyspnoea—Octreotide—thymus cancer	0.00252	0.00308	CcSEcCtD
Donepezil—SIGMAR1—lymph node—thymus cancer	0.00252	0.014	CbGeAlD
Donepezil—Somnolence—Octreotide—thymus cancer	0.00252	0.00307	CcSEcCtD
Donepezil—HTR2A—pituitary gland—thymus cancer	0.00251	0.014	CbGeAlD
Donepezil—Dyspepsia—Octreotide—thymus cancer	0.00249	0.00304	CcSEcCtD
Donepezil—Decreased appetite—Octreotide—thymus cancer	0.00246	0.003	CcSEcCtD
Donepezil—Gastrointestinal disorder—Octreotide—thymus cancer	0.00244	0.00298	CcSEcCtD
Donepezil—Fatigue—Octreotide—thymus cancer	0.00244	0.00298	CcSEcCtD
Donepezil—Pain—Octreotide—thymus cancer	0.00242	0.00295	CcSEcCtD
Donepezil—Constipation—Octreotide—thymus cancer	0.00242	0.00295	CcSEcCtD
Donepezil—Feeling abnormal—Octreotide—thymus cancer	0.00233	0.00284	CcSEcCtD
Donepezil—Gastrointestinal pain—Octreotide—thymus cancer	0.00232	0.00282	CcSEcCtD
Donepezil—Urticaria—Octreotide—thymus cancer	0.00225	0.00274	CcSEcCtD
Donepezil—Abdominal pain—Octreotide—thymus cancer	0.00224	0.00273	CcSEcCtD
Donepezil—Body temperature increased—Octreotide—thymus cancer	0.00224	0.00273	CcSEcCtD
Donepezil—Hypersensitivity—Octreotide—thymus cancer	0.00209	0.00254	CcSEcCtD
Donepezil—Asthenia—Octreotide—thymus cancer	0.00203	0.00248	CcSEcCtD
Donepezil—Pruritus—Octreotide—thymus cancer	0.002	0.00244	CcSEcCtD
Donepezil—HTR2A—lung—thymus cancer	0.00196	0.0109	CbGeAlD
Donepezil—Diarrhoea—Octreotide—thymus cancer	0.00194	0.00236	CcSEcCtD
Donepezil—Dizziness—Octreotide—thymus cancer	0.00187	0.00228	CcSEcCtD
Donepezil—Vomiting—Octreotide—thymus cancer	0.0018	0.00219	CcSEcCtD
Donepezil—Rash—Octreotide—thymus cancer	0.00179	0.00218	CcSEcCtD
Donepezil—Dermatitis—Octreotide—thymus cancer	0.00178	0.00217	CcSEcCtD
Donepezil—Headache—Octreotide—thymus cancer	0.00177	0.00216	CcSEcCtD
Donepezil—Nausea—Octreotide—thymus cancer	0.00168	0.00205	CcSEcCtD
